Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-25-001212
Filing Date
2025-08-19
Accepted
2025-08-19 16:05:30
Documents
1
Period of Report
2025-08-15

Document Format Files

Seq Description Document Type Size
1 e664791_4-sassine.html 4  
1 e664791_4-sassine.xml 4 3675
  Complete submission text file 0001193805-25-001212.txt   5101
Mailing Address 82 DEVONSHIRE STREET BOSTON MA 02109
Business Address
SASSINE ANDY (Reporting) CIK: 0001515322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38942 | Film No.: 251231738

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)